-
The FDA in October approved fosamprenavir calcium (Lexiva), which is manufactured by GlaxoSmithKline of Research Triangle Park, NC, and Vertex Pharmaceuticals Inc. of Cambridge, MA.
-
When you go to the medication room to get an order of morphine, you misread the medication label and mistakenly grab hydromorphone. You catch the error yourself, and no one else is aware of the mix-up. Even if the wrong drug had been given, no adverse event would have been likely to occur. So, would you report this near miss?
-
Do you expect that nurses will come straight to the ED in the event of a major disaster, regardless of their personal needs? Not according to the findings of one new study.
-
The effect of organizational climate on the clinical care of patients with mental health problems; A decision rule for identifying children at low risk for brain injuries after blunt head trauma.
-
Over a year, how would you like to add $9,863 to your EDs bottom line by catching missed charges for supplies or wrong acuity levels?
-
-
To improve patient survival, the emergency physician (EP) must be knowledgeable about current concepts and controversies in the management of patients in shock. No longer can one simply rely on the presence of traditional clinical markers of shock to make the diagnosis. New and innovative monitoring techniques, as well as continually evolving treatment algorithms, are at the forefront of shock research. This article will educate and update the EP on current and future trends in the management of patients in shock. Equipped with this information, the EP more effectively can identify patients in shock, administer the latest evidence-based treatment, and ultimately improve patient outcome.
-
-
Pushed by an unprecedented scientific revolution, the future may yield biologically engineered weapons worse than any disease known to man, a report by the CIA concluded.
-
The Centers for Disease Control and Prevention (CDC) has awarded approximately $9 million in new grants to enhance biodefense and emerging infectious diseases research in the United States.